Delenex Therapeutics Investors

17 investors on Angel Roster list Delenex Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Switzerland and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Delenex Therapeutics can appear together.

Investors listed
17
With verified email
35%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 Delenex Therapeutics investors

The most complete profiles first. Showing 17 of 17.

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Alain NicodVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Arnd Kaltofen

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Benedikt Luhmann

    Venture Capital · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Diego Braguglia

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Kiran Dallenbach

    Venture Capital, Private Equity Firm · Switzerland

    Health CareChemicalLife ScienceBiotechnology

    Portfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more

    Contact details available

  • Stefan Fäs

    Venture Capital, Private Equity Firm · Switzerland

    Health CareChemicalLife ScienceBiotechnology

    Portfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Delenex Therapeutics investors are on Angel Roster?

Angel Roster lists 17 Delenex Therapeutics investors. 6 of them (35%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (17) and Private Equity Firms (9). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Delenex Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (7).

Where are Delenex Therapeutics investors based?

Most are based in the United States (10), Switzerland (6) and the United Kingdom (1).

Which companies have Delenex Therapeutics investors backed?

The most-backed portfolio companies among them are myOrthos (11), ValenTx (11), VHSquared (11), Xilio Therapeutics (11) and Misonix (11).

How do I contact Delenex Therapeutics investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.